Godrej Agrovet crosses Rs. 10,000 crore revenue mark on broad-based growth in FY26

By: ICN Bureau

Last updated : May 02, 2026 1:56 pm



The crop care business remained under pressure due to adverse weather, falling crop acreage and regulatory disruptions


Godrej Agrovet has reported a solid set of results for FY26, with revenues crossing the Rs. 10,000 crore milestone and profits rising sharply, driven by strong performance across its core businesses, particularly oil palm and animal nutrition. 

For the full year ended March 31, 2026, consolidated revenue from operations stood at Rs. 10,233 crore, up from Rs. 9,383 crore in FY25.  

Profit before tax, excluding non-recurring and exceptional items, rose to Rs. 569 crore, compared to Rs. 485 crore a year earlier, reflecting what the company described as improved operational efficiency and a sharper focus on value-added businesses. 

In the fourth quarter alone, revenue increased to Rs. 2,333 crore, up from Rs. 2,134 crore in Q4 FY25, while profit before tax rose to Rs. 87 crore, compared to Rs. 74 crore in the same quarter last year. 

Chief Executive Officer and Managing Director Sunil Kataria said FY26 was a “strong year of delivery” for the company, highlighting both revenue growth and profitability gains. 

“FY 2025–26 marked a strong year of delivery for Godrej Agrovet Limited, with consolidated revenues surpassing Rs. 10,000 crore, growing by 9% year-on-year, while profitability registered a robust 17% growth. This performance underscores the strength of our growth strategy of moving towards value-added portfolio, disciplined execution and sharp focus on improving the quality of earnings,” he said. 

He added that improved working capital management also strengthened cash flows and return on capital employed. 

The oil palm business emerged as a key growth engine, delivering what the company called an “outstanding performance” with strong volume growth, peak oil recovery and margin expansion. The segment’s results surged about 68% year-on-year, making it one of the biggest contributors to overall performance. 

Animal nutrition also posted robust growth, with volumes rising about 12% for the year and 15% in Q4, led by a sharp 18–24% jump in cattle feed volumes and supported by favourable commodity trends. 

A major turnaround was seen in Astec LifeSciences, which reached EBITDA break-even for FY26, driven by improved utilisation, better realisations and stronger demand across enterprise and CDMO businesses. 

In contrast, the crop care business remained under pressure due to adverse weather, falling crop acreage and regulatory disruptions, while the dairy segment was impacted by unseasonal rains and higher milk procurement costs. However, dairy still managed around 5% revenue growth excluding bulk products, with early signs of recovery in value-added products. 

Godrej Foods Limited continued its strategic pivot towards branded products, with branded revenue salience rising above 80% and branded volumes growing around 9%, helping improve earnings quality. 

On the sustainability front, the company said it strengthened its ESG commitments under its Good & Green vision, maintaining an “A–” CDP rating, achieving about 79% renewable energy usage, cutting Scope 1 and 2 emissions by 12.4%, and expanding its water-positive footprint. Astec LifeSciences also secured an EcoVadis Gold rating, placing it among the top 5% of global companies. 

Overall, FY26 positions Godrej Agrovet as a company leaning more heavily on value-added growth, tighter execution, and improved sustainability metrics, even as some segments continue to face cyclical and weather-related pressures.

Godrej Agrovet Limited Animal nutrition Astec LifeSciences Godrej Foods Limited crop care

First Published : May 02, 2026 12:00 am